143 Episodes

  1. Immunotherapy rechallenge in NSCLC

    Published: 3/3/2022
  2. ESO’s career development programme

    Published: 2/24/2022
  3. Summary/Review - Reporting Guidelines - CONSORT

    Published: 2/17/2022
  4. Summary/Review: Long-term results of SNB after NCT for primary cN1/2 breast who convert to cN0

    Published: 2/10/2022
  5. Summary/Review: Pathology after neoadjuvant treatment for breast cancer – How to assess residual disease.

    Published: 2/3/2022
  6. Intraoperative breast ultrasound

    Published: 1/27/2022
  7. Summary/Review - Reporting Guidelines - PRISMA 2020

    Published: 1/20/2022
  8. Summary/Review - The use of Artificial Intelligence in the Oncology field. Addressing all the hype and skepticism.

    Published: 1/13/2022
  9. Advanced Gastric Cancer

    Published: 12/9/2021
  10. PARP inhibitors for the treatment of ovarian cancer

    Published: 12/2/2021
  11. The role of clinician-scientists in modern oncology

    Published: 11/25/2021
  12. Pharmacologic interactions with new drugs

    Published: 11/18/2021
  13. Positive Resection Margins in Colon Cancer

    Published: 11/11/2021
  14. Immunotherapy in Lung Cancer

    Published: 11/4/2021
  15. Low HR positive breast cancer

    Published: 10/28/2021
  16. Possibilities of tackling side effects of cancer therapies

    Published: 10/21/2021
  17. Fertility preservation in young cancer patients

    Published: 10/14/2021
  18. CDK4/6i in HR+HER2- breast cancer

    Published: 10/7/2021
  19. Treatment selection in castration-resistant prostate cancer

    Published: 9/30/2021
  20. Questions and Controversies in Localized Head and Neck Cancer

    Published: 9/23/2021

6 / 8

e-ESO is the online platform of the European School of Oncology providing sponsor-free, open access quality education wherever you are in the world. www.e-Eso.net